首页> 美国政府科技报告 >Medical Research and Evaluation Facility (MREF) and Studies Supporting theMedical Chemical Defense Program: Development of Procedures to Enhance Atropine Antisera Production in Rabbits
【24h】

Medical Research and Evaluation Facility (MREF) and Studies Supporting theMedical Chemical Defense Program: Development of Procedures to Enhance Atropine Antisera Production in Rabbits

机译:医学研究和评估机构(mREF)和支持医学化学防御计划的研究:开发增强兔子阿托品抗血清生产的程序

获取原文

摘要

The purpose of this study was to improve the production of rabbit anti-atropineantisera for future analytical studies. There were two phases to this project: evaluation of methods to enhance atropine antisera titers, and antisera production and characterization. Anti-atropine antisera were prepared using a high-density conjugate. The radioimmunoassay performance characteristics were similar for both the Battelle and Walter Reed Army Institute of Research antisera. However, a lower detection limit and a more dynamic response range were obtained with the Battelle antisera. Minor changes were made in the atropine radioimmunoassay to improve its reliability. There were approximately 250 mL of atropine antisera collected during this project, providing a useful antisera supply adequate for 250,000 tests.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号